Distinguishing social and medical traits: perspectives of scientists using polygenic scores
July 9, 2026
Tag: Margaret Waltz
Perceptions of Polygenic Scores for Medical and Social Traits among Biobank Participants and the General Public
July 9, 2026
Ethical Complexities in Contraceptive Mandates for Adolescent Clinical Trial Participation: A Qualitative Analysis of U.S. Adolescents’ Perspectives
July 1, 2026
The stigma of seriousness: views of genome editing scientists and policy professionals on defining serious disease
June 26, 2025
Enhancing Animals is “Still Genetics”: Perspectives of Genome Scientists and Policymakers on Animal and Human Enhancement
December 23, 2024
Group-based medical mistrust in genomic medicine: Associations with patient and provider perceptions of a specialty clinical encounter
September 25, 2024
Margaret Waltz, Jonathan S. Berg Co-Authors on New Genetics in Medicine Article
September 25, 2024
Margaret Waltz and Jonathan S. Berg are co-authors, with colleagues, on a new article in Genetics in Medicine. The researchers “investigated associations between GBMM [group-based medical mistrust]” and perceptions of a specialty care appointment. The study includes perspectives from caregivers of child patients and from providers. Findings “extend evidence for...
Challenging the Boundaries Between Treatment, Prevention, and Enhancement in Human Genome Editing
July 23, 2024
A Review of the Institutional Landscape for Dual-career Hiring in Higher Education.
April 6, 2024
Exclusion of Women from Phase I Trials: Perspectives from Investigators and Research Oversight Officials
November 27, 2023